Covid-19 vaccine shortages hit 60 poor countries in 'shocking imbalance'

Shortage stems mostly from India's decision to stop exporting vaccines from its Serum Institute factory, which produces the overwhelming majority of the AstraZeneca doses.

A woman at Kenyatta National Hospital in Nairobi, Kenya, receives a dose of AstraZeneca COVID-19 vaccine manufactured by SII and provided through the global COVAX initiative. (AP Photo/Brian Inganga, File)
Premium

A woman at Kenyatta National Hospital in Nairobi, Kenya, receives a dose of AstraZeneca COVID-19 vaccine manufactured by SII and provided through the global COVAX initiative. (AP Photo/Brian Inganga, File)

Lori Hinnant and Maria Cheng, Associated Press | PTI
As many as 60 countries, including some of the world’s poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help them are blocked until as late as June.

COVAX, the global initiative to provide vaccines to countries lacking the clout to negotiate for scarce supplies on their own, has in the past week shipped more than 25,000 doses to low-income countries only twice on any given day. Deliveries have all but halted since Monday.

During the past two weeks, according to data compiled daily by UNICEF, fewer than 2 million COVAX doses in total were cleared for shipment to 92 countries in the developing world — the

First Published: Apr 11 2021 | 07:08 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com